MAH name | e-mail address | Phone number |
A. Menarini Manufacturing Logistics and Services | reclami@menarini.it | +39 055.56809598
(active from monday to friday, from 08.30 a.m. to 05.30 p.m.) |
AbbVie Deutschland GmbH & Co. KG & AbbVie SIA | GPO-EUFMD-Hypercare@abbvie.com | Not provided |
ABC pharma SIA | e.vasilevskis@abcpharma.lv | +371 27816264 |
Actavis Group PTC ehf | FMDAlerts@teva.lt | +371 67 323 666 |
Allergan Pharmaceuticals International Limited | TraceLink_EU_Hypercare@allergan.com | Not provided |
Amgen Europe BV | medinfonb@amgen.com | +370 5219 7461 |
AS Grindeks | Diana.ratkevica@grindeks.lv | +37127892603 |
AS Grindeks | Natalja.kirejenkova@grindeks.lv | +37120004405 |
AS Kalceks | kalceks@kalceks.lv | +371 67083320 |
AS KEVELT | kevelt@kevelt.ee | +372 606 6969 |
AstraZeneca AB (local representative – SIA AstraZeneca Latvija) | Latvia@astrazeneca.com | +371 67377100 |
Bayer AG | quality.baltics@bayer.com
|
+370 52 33 68 68
+370 615 69 031 |
Boehringer Ingelheim International GmbH, Germany | alertmanagement.lv@boehringer-ingelheim.com | +371 67240011 |
Bristol Myers Squibb EEIG | medinfo.latvia@amicuspharma.eu | +371 6770 8347 |
Bristol Myers Squibb Kft | medinfo.latvia@amicuspharma.eu | +371 6770 8347 |
Briz Ltd | linda.meska@briz.lv | +371 67259281 |
Chiesi Farmaceutici S.p.A., Italy | serialization.cee@chiesi.com | +43 676 88 55 55 18 |
Chiesi Pharmaceuticals GmbH, Austria | serialization.cee@chiesi.com | +43 676 88 55 55 18 |
Correvio | medinfo@correvio.com | +41 848 00 79 70 |
Correvio | medinfo@correvio.com | +41 848 00 79 70 |
Daiichi Sankyo Europe GmbH | qc_complaints@daiichi-sankyo.eu | +49 8441 759 0 |
Egis Pharmaceuticals PLC | fmd-alert@egis.hu | Not provided |
ELVIM SIA | hq@elvim.lv | +371 67 808 450 |
Exeltis Baltics | responsibleperson@actiopharma.com; Edgar.Diez@Exeltis.com | +370 37 270 771; +34 680 157 354 |
Fidia Farmaceutici SpA | SDeGasperi@fidiapharma.it | (+39) 0498232691 |
Fresenius Kabi Deutschland GmbH, Germany | complaints.baltics@fresenius-kabi.com | +370 686 39065 |
Fresenius Kabi Oncology Plc, UK | complaints.baltics@fresenius-kabi.com | +370 686 39065 |
Fresenius Kabi Polska Sp.z.o.o | complaints.baltics@fresenius-kabi.com | +370 686 39065 |
G. L. Pharma GmbH | serialisation@gl-pharma.at | +43(0)3136/82577-90 |
Gedeon Richter | ALERT@richter.hu | Not provided |
GlaxoSmithKline Latvia SIA | lv-epasts@gsk.com | +371 67312687 |
HCS bvba, Belgium | serialization.alerts@krka.biz | 00386 51 205 742 |
Helixor Heilmittel GmbH | serialisierung@helixor.de | 0049-7428-9350 |
Helixor Heilmittel GmbH | serialisierung@helixor.de | 0049-7428-9350 |
Hennig Arzneimittel GmbH & Co. KG | qs@hennig-am.de | 06145 508 0 |
Ipsen Pharma SAS | ipsenserialization@ipsen.com | Not provided |
Janssen Biologics B.V. | dpoc.latvia@merck.com | + 371 67 025 300 |
Janssen-Cilag International NV | RA-JACLT-QA-Baltics@ITS.JNJ.com | +371 678 93561 |
JSC Inteli Generics Nord | office@maxpharma.lt | +3702730893; +37067027401 |
Krka, d.d., Novo mesto, Slovenia | serialization.alerts@krka.biz | 00386 51 205 742 |
Laboratorios Farmacéuticos ROVI, S.A.
|
registros@rovi.es | switchboard telephone: + 34 91 375 62 30
Regulatory affairs department: + 34 91 375 62 51 |
Les Laboratoires Servier | mail.ic-quality-complaints@servier.com | +33 1 55 72 60 00 |
medac Gesellschaft für klinische Spezialpräparate mbH | alsified@medac.de | +49 (0)4103 8006-0 |
medac Gesellschaft für klinische Spezialpräparate mbH, Germany | info@viasana.lt | +370 5 278 8414 |
Merck Europe B.V. | Inese.sumilova@merckgroup.com
Guna.dansone@merckgroup.com |
+371 67 152 513;
+371 67 152 522 |
Merck KGaA | Inese.sumilova@merckgroup.com
Guna.dansone@merckgroup.com |
+371 67 152 513;
+371 67 152 522 |
Merck Sante s.a.s. | Inese.sumilova@merckgroup.com
Guna.dansone@merckgroup.com |
+371 67 152 513;
+371 67 152 522 |
Merck Serono S.p.A. | Inese.sumilova@merckgroup.com
Guna.dansone@merckgroup.com |
+371 67 152 513;
+371 67 152 522 |
Merus Labs Luxco II S.à.r.l. | serialisation.europe@norgine.com | +41 41 561 36 18 |
Mundipharma Gesellschaft m.b.H., Austria | quality@mundipharma.at | + 43 1 523 25 05-0 |
Norgine BV | serialisation.europe@norgine.com | +31 20 567 09 00 |
Novo Nordisk A/S | EUalert@novonordisk.com | 67257577 |
Omrix Biopharmaceuticals N.V. | RA-JACLT-QA-Baltics@ITS.JNJ.com | +371 678 93561 |
ORIVAS UAB | info@orivas.lt | +370 5 252 6570 |
Otsuka Pharmaceuticals Netherlands BV | FMalerts@otsuka-europe.com | +44 (0) 203 747 5000 |
Ratiopharm GmbH | FMDAlerts@teva.lt | +371 67 323 666 |
Roche Latvija SIA | latvia.quality@roche.com | +37167 039 831 |
Roche Registration GmbH | latvia.quality@roche.com | +37167 039 831 |
Santen Oy | olli.puhakka@santen.com | +358405598913 |
SIA “PHARMAMAX” | info@pharmamax.lv | +371 26873719 |
SIA ‘’Merck Sharp & Dohme Latvija’’ | dpoc.latvia@merck.com | +371 67025300 |
SIA “Baltijas Terapeitiskais Serviss” | offis@btsplazma.lv | +371 67450905 |
SIA “Jelgavfarm” | jelgavfarm@apollo.lv | +371 63022249 |
SIA Livorno Pharma | info@livorno.lv | 27880019 |
SIA Merck Serono | Inese.sumilova@merckgroup.com
Guna.dansone@merckgroup.com |
+371 67 152 513;
+371 67 152 522 |
SIA Ņovartis Baltics” | dra.latvia@novartis.com; qa.baltics@novartis.com | +371 67 887 070 |
SIA SERVIER LATVIA | Not provided | +371 67502039 |
Swedish Orphan Biovitrum AB | TLAlerts@sobi.com | +46(0)735186039 (Monday-Friday, 08:30-16:45 CET) |
Swedish Orphan Biovitrum AB (Publ) | TLAlerts@sobi.com | +46 (0) 735 18 60 39 |
Swedish Orphan Biovitrum International AB | TLAlerts@sobi.com | +46 (0) 735 18 60 39 |
Swedish Orphan Biovitrum International AB | TLAlerts@sobi.com | +46(0)735186039 (Monday-Friday, 08:30-16:45 CET) |
TAD Pharma GmbH, Germany | serialization.alerts@krka.biz | 00386 51 205 742 |
Teva B.V. | FMDAlerts@teva.lt | +371 67 323 666 |
Teva GmbH | FMDAlerts@teva.lt | +371 67 323 666 |
Teva Pharma B.V. | FMDAlerts@teva.lt | +371 67 323 666 |
UAB “JOHNSON & JOHNSON” | RA-JACLT-QA-Baltics@ITS.JNJ.com | +371 678 93561 |
UAB Norameda | info@norameda.lt | +370 (5) 230 64 99 |
UAB SanoSwiss, Lithuania
Rivopharm Ltd., Ireland |
serialization@sanoswiss.com | +370 700 01320 |
WÖRWAG Pharma GmbH & Co. KG | torsten.voss@woerwagpharma.com | + 49 7031 6204 543; +49 7031 6204 100 |